Loading...

NuVasive, Inc.

NUVANASDAQ
Healthcare
Medical - Devices
$39.75
$-0.91(-2.24%)

NuVasive, Inc. NUVA Peers

See (NUVA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
NUVA$39.75-2.24%2.1B75.00$0.53N/A
ABT$125.64-0.15%218.6B15.76$7.97+1.84%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$106.21-1.44%157B63.18$1.68N/A
SYK$396.66-1.07%151.6B53.70$7.39+0.83%
MDT$92.32+0.34%118.3B25.58$3.61+3.04%
EW$75.80-1.44%44.4B31.27$2.42N/A
DXCM$86.74+0.36%34B65.22$1.33N/A
PHG$25.84-0.04%23.9B86.13$0.30+3.43%
STE$227.25+0.79%22.4B36.90$6.16+1.00%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

NUVA vs ABT Comparison

NUVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUVA stands at 2.1B. In comparison, ABT has a market cap of 218.6B. Regarding current trading prices, NUVA is priced at $39.75, while ABT trades at $125.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUVA currently has a P/E ratio of 75.00, whereas ABT's P/E ratio is 15.76. In terms of profitability, NUVA's ROE is +0.05%, compared to ABT's ROE of +0.32%. Regarding short-term risk, NUVA is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for NUVA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;